Vimarsana
Biggest News Aggregation in the World

Page 26 - Regulated Information News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Regulated Information. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Regulated Information Today - Breaking & Trending Today

IPSOS: Monthly declaration of shares and voting rights - April 2023 - Vimarsana News

IPSOS: Monthly declaration of shares and voting rights - April 2023

31.05.2023 - May 31, 2023 MONTHLY DISCLOSURE OF THE TOTAL NUMBER OF SHARES AND VOTING RIGHTS Articles L. 233-8 II of the Commercial Code and 223-16 of the General Regulation of the AMF Date   Shares   Voting rights Theoretical* Exercisable** ...

Related Topics:
Regulated Information
Information on the Total Number of Voting Rights - Vimarsana News

Information on the Total Number of Voting Rights

Regulated Information - Denominator Atlas Special Opportunities, LLC has converted 22 convertible bonds in Oxurion resulting in a EUR 550,000 capital...

Oxurion NV: Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from ATLAS - Vimarsana News

Oxurion NV: Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from ATLAS

Regulated Information - Denominator Atlas Special Opportunities, LLC has converted 22 convertible bonds in Oxurion resulting in a EUR 550,000 capital increase. This is part of Atlas

Oxurion NV: Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from ATLAS - Vimarsana News

Oxurion NV: Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from ATLAS

Regulated Information - Denominator Atlas Special Opportunities, LLC has converted 4 convertible bonds in Oxurion resulting in a EUR 100,000 capital increase. This is part of Atlas Special

Oxurion Reaches Enrollment Target in KALAHARI Phase 2, Part B Trial of Novel PKal Inhibitor THR-149 in Diabetic Macular Edema - Vimarsana News

Oxurion Reaches Enrollment Target in KALAHARI Phase 2, Part B Trial of Novel PKal Inhibitor THR-149 in Diabetic Macular Edema

                                                       ... | May 25, 2023